Posted on 08/12/202509/01/2026 by Innovator Awards Prof. Dr. Yanqi Dang | CRC | Best Scholar Award Shanghai University of Traditional Chinese Medicine | China Yanqi Dang is an established researcher at Longhua Hospital, Shanghai University of Traditional Chinese Medicine. He has a Ph.D. in Chinese Pharmacology and a strong academic background in biological sciences. Over his career, he has published 47 peer-reviewed papers, and his work has been cited about 880 times — giving him an h-index of 20. Scinapse His research primarily focuses on colorectal carcinoma and non-alcoholic fatty liver disease (NAFLD), exploring mechanisms involving epigenetics and investigating potential antitumor or hepatoprotective compounds from traditional Chinese medicine. Among his recent work is a study showing that a decoction improves hepatic steatosis through ALKBH1-mediated DNA N6-methyladenosine modification. Frontiers+1 With a sustained publication record and growing influence in the fields of oncology and metabolic liver disease, he is recognized as a dedicated contributor to integrating modern scientific methods with traditional medicine. Citation Metrics (Scopus) 1000 800 600 400 200 0 Citations 927 Documents 45 h-index 20 Citations Documents h-index View Scopus Profile Featured Publications Emodin Enhances Rosiglitazone’s Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis – Pharmaceuticals, 2025 Tet Methylcytosine Dioxygenase 3 Promotes Cardiovascular Senescence via 5-Hydroxymethylcytosine-Mediated Sp1 Expression – MedComm, 2025 Regulation of Histone H3K27 Methylation in Inflammation and Cancer – Molecular Biomedicine, 2025 The Role of N6-Methyladenosine in Macrophage Polarization: A Novel Treatment Strategy for NASH – Biomedicine & Pharmacotherapy, 2024 tRNA-Derived Fragments as Promising Biomarkers for Early Colorectal Cancer Screening – MedComm, 2023 Yanqi Dang | CRC | Best Scholar Award